Loading
Latest filing published 04 Feb 2026 for Interpace Biosciences, INC., €24.1M.
No signal scores available.
Our data holds just one disclosure by Ampersand 2018 Limited Partnership, dated 4 February 2026, reporting a transaction worth €24.1M in Interpace Biosciences, Inc. Further filings will be added here. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration